Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.58 |
| ▸ | GAA | P10253 | 5/20 | 0.58 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL20984992 | 0.98 | KMT2A (0.56) | KMT2AGAAMAPTMEN1LMNA | |
| Hydrochloric Acid SCHEMBL20984230 | 0.98 | KMT2A (0.57) | KMT2AGAAMAPTMEN1LMNA | |
| Sulfuric Acid SCHEMBL20984898 | 0.89 | GAA (0.53) | KMT2AGAAMAPTMEN1LMNA | |
| Oxalic Acid SCHEMBL20984400 | 0.89 | GAA (0.56) | KMT2AGAAMAPTMEN1ALDH1A1 | |
| Phosphoric Acid SCHEMBL20984636 | 0.89 | GAA (0.56) | KMT2AGAAMAPTMEN1LMNA | |
| Nitric Acid SCHEMBL20984863 | 0.87 | KMT2A (0.51) | KMT2AGAAMAPTMEN1LMNA | |
| SCHEMBL10608641 | 0.83 | ALDH1A1 (0.59) | KMT2AGAAMAPTMEN1LMNA | |
| Hydrochloric Acid SCHEMBL25414844 | 0.82 | ALDH1A1 (0.58) | KMT2AGAAMAPTMEN1LMNA | |
| Bromide SCHEMBL20984609 | 0.82 | ALDH1A1 (0.58) | KMT2AGAAMAPTMEN1LMNA | |
| Hydrochloric Acid SCHEMBL20984855 | 0.82 | ALDH1A1 (0.58) | KMT2AGAAMAPTMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107236106-A | The aromatic series terminal hydroxy group chain extender of the key containing acylhydrazone, selfreparing polyurethane and preparation method thereof | 青岛科技大学 | 2017-10-10 | — | — | CN | claimed |
| CN-107236106-B | Aromatic hydroxyl-terminated chain extender containing acylhydrazone bond, self-repairing polyurethane and preparation method of chain extender | 青岛科技大学 | 2020-01-07 | — | — | CN | disclosed |
| CN-107236106-A | The aromatic series terminal hydroxy group chain extender of the key containing acylhydrazone, selfreparing polyurethane and preparation method thereof | 青岛科技大学 | 2017-10-10 | — | — | CN | disclosed |
| EP-2380879-B1 | Tetrahydroindolone and tetrahydroindazolone derivatives | ESANEX INC (US) | 2017-07-12 | — | — | EP | disclosed |
| US-20160114042-A1 | AMINE-CONTAINING LIPIDOIDS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2016-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160114042-A1 | AMINE-CONTAINING LIPIDOIDS AND USES THEREOF | ABCB4, PHOSPHO1, SGMS2 | KMT2A 267/4885GAA 3184/4885MAPT 3385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.